GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » C-Mer Eye Care Holdings Ltd (HKSE:03309) » Definitions » Total Assets

C-Mer Eye Care Holdings (HKSE:03309) Total Assets : HK$2,749 Mil (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is C-Mer Eye Care Holdings Total Assets?

C-Mer Eye Care Holdings's Total Assets for the quarter that ended in Dec. 2023 was HK$2,749 Mil.

Warning Sign:

If a company builds assets at 65.3% a year, faster than its revenue growth rate of 32.8% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, C-Mer Eye Care Holdings's average Total Assets Growth Rate was -0.50% per year. During the past 3 years, the average Total Assets Growth Rate was 26.80% per year. During the past 5 years, the average Total Assets Growth Rate was 65.30% per year.

During the past 10 years, C-Mer Eye Care Holdings's highest 3-Year average Total Assets Growth Rate was 116.30%. The lowest was 21.80%. And the median was 55.70%.

Total Assets is connected with ROA %. C-Mer Eye Care Holdings's annualized ROA % for the quarter that ended in Dec. 2023 was 2.36%. Total Assets is also linked to Revenue through Asset Turnover. C-Mer Eye Care Holdings's Asset Turnover for the quarter that ended in Dec. 2023 was 0.36.


C-Mer Eye Care Holdings Total Assets Historical Data

The historical data trend for C-Mer Eye Care Holdings's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C-Mer Eye Care Holdings Total Assets Chart

C-Mer Eye Care Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,119.65 1,629.21 1,955.88 2,901.69 2,748.64

C-Mer Eye Care Holdings Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,955.88 2,889.24 2,901.69 2,706.03 2,748.64

C-Mer Eye Care Holdings Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

C-Mer Eye Care Holdings's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=1993.286+755.349
=2,749

C-Mer Eye Care Holdings's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (Q: Dec. 2023 )+Total Liabilities (Q: Dec. 2023 )
=1993.286+755.349
=2,749

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C-Mer Eye Care Holdings  (HKSE:03309) Total Assets Explanation

Total Assets is connected with ROA %.

C-Mer Eye Care Holdings's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=64.48/( (2706.033+2748.635)/ 2 )
=64.48/2727.334
=2.36 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

C-Mer Eye Care Holdings's Asset Turnover for the quarter that ended in Dec. 2023 is

Asset Turnover
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=973.701/( (2706.033+2748.635)/ 2 )
=973.701/2727.334
=0.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

C-Mer Eye Care Holdings Total Assets Related Terms

Thank you for viewing the detailed overview of C-Mer Eye Care Holdings's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


C-Mer Eye Care Holdings (HKSE:03309) Business Description

Traded in Other Exchanges
N/A
Address
1-3 Pedder Street, Suite 1335, Central Building, Central, Hong Kong, HKG
C-Mer Eye Care Holdings Ltd provides general medical and surgical hospital services. It provides ophthalmic health care, diagnosis, treatment, surgical treatment services, and the sale of vision aid and pharmaceutical products in Hong Kong and the People's Republic of China. The company offers cataract, cornea, and ocular surface diseases, glaucoma, vitreoretinal and macular diseases, other eye diseases diagnosis and treatment services, and Chinese medicine treatment of eye diseases. Its segments include Sales of medical consumables, Mainland China ophthalmic business and Mainland China dental business. It generates a vast majority of its revenue from the provision of the ophthalmic services segment.
Executives
C-mer Group Limited 2101 Beneficial owner
Lam Shun Chiu Dennis 2201 Interest of corporation controlled by you
Li Xiaoting 2201 Interest of corporation controlled by you

C-Mer Eye Care Holdings (HKSE:03309) Headlines

No Headlines